Mustargen and Breastfeeding
Even though no adequate research has been done on using Mustargen (mechlorethamine) while breastfeeding, it is expected that this drug would likely pass through breast milk to some extent. Because potentially serious side effects are associated with this drug, the manufacturer recommends that women avoid breastfeeding while undergoing this chemotherapy treatment.
Can Breastfeeding Women Use Mustargen?Mustargen® (mechlorethamine) is a prescription chemotherapy medication. At this time, it is unknown whether Mustargen passes through breast milk. The manufacturer of the medication recommends women avoid breastfeeding during treatment with Mustargen.
More Information on Mustargen and BreastfeedingThis medication has not been studied during breastfeeding, and there is no information describing its use in women who are nursing. Based on the properties of Mustargen, it is expected to pass through breast milk to some extent. However, because of the lack of information, it is unknown for certain if the medicine passes through breast milk, or if it would harm a nursing child.
Mustargen is associated with potentially serious side effects, including the risk for infection, anemia, and bleeding. Until more information is known, the possibility that these and other harmful Mustargen side effects could occur in a breastfeeding child cannot be ruled out. Therefore, it is generally recommended that women receiving this drug avoid breastfeeding.
Talking With Your Healthcare ProviderYou should discuss breastfeeding and Mustargen use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.